ABOUT

A clearer picture of the patient

EXINI Diagnostics provides advanced products for image analysis, targeted towards prostate cancer.

EXINI’s technology was developed using unique image analysis derived from expert knowledge in medicine, image analysis, handling of large databases, and artificial neural networks (ANN).

Our products provide you with high quality visualization, quantification and unique decision support .

EXINI does business handling everything I find fascinating – combining the prospect of good business with excellent science and an ambition to help making people’s lives better.

Bo Håkansson

Former Chairman of the board

Bo Håkansson

Management

Jeff Summer, Site Manager

Andreas Järund, CTO

Andreas joined EXINI at start up upon graduation from Lund University, and has held several positions within the company, mainly in development. Andreas Järund holds an MSc in Engineering Physics.

Aseem Anand, CPO

Certified Clinical Research Professional (CCRP) with experience in clinical research management at Memorial Sloan Kettering Cancer Center, USA. Participated in the successful execution of 510K approval of Veridex Cell Search for detection of CTC in metastatic prostate cancer. Successfully defended PhD thesis in imaging biomarker development and validation in metastatic Prostate Cancer at Lund University, Sweden.

Lars Edenbrandt, Medical & Scientific Director

MD, PhD and founder of EXINI. Lars is Professor and Senior Physician in Nuclear Medicine at Sahlgrenska University Hospital in Gothenburg and Senior Physician at Skåne University Hospital in Malmö.

Board of Directors

 

Member since

2015

Shares

0

Mr. Baker joined the Company in 2005 as Senior Vice President & General Counsel and Secretary. In 2008, he was appointed Executive Vice President – Corporate, in 2009 became President, and has been CEO since March 2011. From 2003 to 2005, Mr. Baker was Chief Business Officer, Secretary and a director of New York Trans Harbor LLC, a privately-held ferry operation in New York City. From 1997 to 2001, he was Executive Vice President, Chief Legal Officer and Secretary of Continental Grain Company, a privately-held international agri-business and financial concern. Prior thereto, he was a partner and Co-Chairman of the Capital Markets Group of the New York law firm Dewey Ballantine. Mr. Baker has an A.B. degree from Columbia College and a J.D. from the Columbia University School of Law.

Mark R. Baker

Chairman of the board

Member since

2017

Shares

0

Certified Clinical Research Professional (CCRP) with experience in clinical research management at Memorial Sloan Kettering Cancer Center, USA. Participated in the successful execution of 510K approval of Veridex Cell Search for detection of CTC in metastatic prostate cancer. Successfully defended PhD thesis in imaging biomarker development and validation in metastatic Prostate Cancer at Lund University, Sweden.

Aseem Anand

Member of the board